Patents by Inventor Claire Mallard

Claire Mallard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11224566
    Abstract: A composition comprising, in a physiologically acceptable medium, a crosslinked hyaluronic acid (HA), having a degree of modification less than 1.9 mole %; a HA with a molecular weight of about 50 kDa or less; and/or an agent stimulating endogenous HA synthesis. Also disclosed is a cosmetic use of such composition in skin care and/or anti-ageing treatment.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: January 18, 2022
    Assignee: Galderma Holding SA
    Inventors: Claire Mallard, Yves Rival
  • Patent number: 11197831
    Abstract: A composition is described that includes lipid microcapsules and at least one dispersed active principle. A method is also described for preparing the composition. Also described, is the use of the composition in the treatment of dermatological diseases.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: December 14, 2021
    Assignee: GALDERMA RESEARCH AND DEVELOPMENT
    Inventors: Carole Dubayle, Claire Mallard, Nicolas Atrux-Tallau
  • Patent number: 11154565
    Abstract: A process is described for preparing a stable emulsion that includes at least one avermectin. Also described, is the emulsion thus obtained, especially for use in the treatment of dermatological disorders such as rosacea.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: October 26, 2021
    Assignee: Galderma Holding SA
    Inventors: Claire Mallard, Richard Dugat, Elodie Roger, Ricardo Diaz
  • Publication number: 20210220269
    Abstract: The invention relates to a composition in the form of a water-in-oil (W/O) emulsion suitable for topical administration.
    Type: Application
    Filed: March 26, 2021
    Publication date: July 22, 2021
    Inventors: Claire MALLARD, Gareth WINCKLE, Emmanuelle GUTIERREZ, Carole DUBAYLE
  • Patent number: 10959934
    Abstract: A micro- or nanoparticular vesicle comprises at least a crosslinked hyaluronic acid (HA), wherein the crosslinked hyaluronic acid is crosslinked by a chemical crosslinking agent, and wherein the degree of modification of said crosslinked hyaluronic acid with said chemical crosslinking agent is less than 1.9 mole %. Also disclosed are a method of manufacturing such vesicles, compositions comprising such vesicles and their uses.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: March 30, 2021
    Assignee: GALDERMA HOLDING SA
    Inventors: Claire Mallard, Yves Rival
  • Patent number: 10925814
    Abstract: Stable cream gel dermatological/cosmetic compositions useful, e.g., for the treatment of acne vulgaris, contain, formulated into a physiologically acceptable medium, a homogeneous dispersion of at least one dispersed retinoid, dispersed benzoyl peroxide, at least one lipophilic compound and at least one gelling agent.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: February 23, 2021
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Mallard, Fabienne Louis, Emmanuelle At Guillet
  • Patent number: 10925855
    Abstract: A composition or nanosuspension is described that includes water dispersible nanoparticles of a retinoid compound having an average particle size of less than about 500 nm. Also described, are pharmaceutical compositions intended for topical administration, including such a composition or nanosuspension. Uses of such pharmaceutical compositions in the treatment of skin diseases, particularly acne, ichthyosis and psoriasis are also described.
    Type: Grant
    Filed: June 23, 2016
    Date of Patent: February 23, 2021
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Mallard, Amel Safia Djedour
  • Patent number: 10857080
    Abstract: Lipid microcapsules are described that can include at least one lipophilic active substance, more specifically a retinoid, in a soluble form. Also described, are pharmaceutical compositions including the same and a method for the production thereof. Methods of using such a composition to treat dermatological pathologies are also described.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: December 8, 2020
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Mallard, Carole Dubayle
  • Patent number: 10849854
    Abstract: A process is described for preparing a composition in the form of an emulsion that includes a high concentration of one or more avermectins. This process can include partitioning the avermectin between an active phase, including at least one glycol, and an oily phase of the emulsion. A composition thus obtained, is also described that can be used in the treatment of dermatological disorders such as rosacea.
    Type: Grant
    Filed: October 13, 2016
    Date of Patent: December 1, 2020
    Assignee: GALDERMA S.A.
    Inventors: Claire Mallard, Elodie Roger
  • Patent number: 10772807
    Abstract: Lipid microcapsules are described that can include at least one irritant active substance, more specifically a retinoid, in a soluble form. Also described, are pharmaceutical compositions comprising the same, and methods for the production thereof. A method of using the composition to treat dermatological pathologies is also described.
    Type: Grant
    Filed: December 4, 2014
    Date of Patent: September 15, 2020
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Mallard, Carole Dubayle
  • Patent number: 10744112
    Abstract: Composition comprising avermectin compounds without solvents and propenetrating agents of avermectin compounds The invention relates to a dermatological or pharmaceutical composition comprising at least one aqueous phase and at least one fatty phase comprising one or more fatty compounds different from solvents and/or propenetrating agents of avermectin compounds and a least one active compound chosen from avermectin compounds, where the composition comprises neither solvents nor propenetrating agents of avermectin compounds. The invention relates also to the composition for use in the treatment of rosacea, of common acne, of seborrheic dermatitis, of perioral dermatitis, of acneiform rashes, of transient acantholytic dermatosis, of acne necrotica miliaris and of atopic dermatitis, and preferably for use in the treatment of rosacea. Finally, the invention relates to a method for preparing the composition.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: August 18, 2020
    Assignee: NESTLÉ SKIN HEALTH S.A.
    Inventor: Claire Mallard
  • Patent number: 10744147
    Abstract: Composition comprising avermectin compounds without solid fatty substances The invention relates to a dermatological or pharmaceutical composition comprising at least one aqueous phase and at least one active phase comprising at least one active compound chosen from avermectin compounds and at least one solvent and/or propenetrating agent of avermectin compounds, where the composition comprises less than 3% by weight of solid fatty substances at room temperature and at atmospheric pressure, relative to the total weight of the composition. The invention relates also to the composition for use in the treatment of rosacea, of common acne, of seborrheic dermatitis, of perioral dermatitis, of acneiform rashes, of transient acantholytic dermatosis, of acne necrotica miliaris and of atopic dermatitis, and preferably for use in the treatment of rosacea. Finally, the invention relates to a method for preparing the composition.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: August 18, 2020
    Assignee: NESTLÉ SKIN HEALTH S.A.
    Inventor: Claire Mallard
  • Patent number: 10702604
    Abstract: Lipid nanocapsules are described that include at least one irritating active ingredient, and more specifically a retinoid in solubilized form. Also described, are nanodispersions and pharmaceutical compositions including the same and methods of producing the same. The use of the pharmaceutical compositions in the treatment of dermatological pathologies is also described.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: July 7, 2020
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventor: Claire Mallard
  • Patent number: 10702466
    Abstract: Stable dermatological/cosmetic emulsions useful, e.g., for the treatment of acne vulgaris, contain, formulated into a physiologically acceptable medium, a homogeneous dispersion of at least one dispersed retinoid, dispersed benzoyl peroxide, at least one fatty phase, at least one hydrophilic phase and at least one emulsifier.
    Type: Grant
    Filed: June 22, 2009
    Date of Patent: July 7, 2020
    Assignee: GALDERMA RESEARCH & DEVELOPMENT
    Inventors: Claire Mallard, Fabienne Louis, Nathalie Willcox
  • Patent number: 10695315
    Abstract: The invention relates to a dermatological or pharmaceutical composition comprising at least one aqueous phase, at least one fatty phase comprising one or more fatty compounds and at least one active phase comprising one or more active compounds chosen from avermectin compounds and one or more solvents and/or propenetrating agents of avermectin compounds, where the composition does not comprise gelling agent. The invention relates also to the composition for use in the treatment of rosacea, of common acne, of seborrheic dermatitis, of perioral dermatitis, of acneiform rashes, of transient acantholytic dermatosis, of acne necrotica miliaris and of atopic dermatitis, and preferably for use in the treatment of rosacea. Finally, the invention relates to a method for preparing the composition.
    Type: Grant
    Filed: November 23, 2017
    Date of Patent: June 30, 2020
    Assignee: NESTLÉ SKIN HEALTH S.A.
    Inventor: Claire Mallard
  • Publication number: 20190314263
    Abstract: A composition comprising, in a physiologically acceptable medium, a crosslinked hyaluronic acid (HA), having a degree of modification less than 1.9 mole %; a HA with a molecular weight of about 50 kDa or less; and/or an agent stimulating endogenous HA synthesis. Also disclosed is a cosmetic use of such composition in skin care and/or anti-ageing treatment.
    Type: Application
    Filed: June 26, 2019
    Publication date: October 17, 2019
    Inventors: Claire MALLARD, Yves RIVAL
  • Publication number: 20190314262
    Abstract: A micro- or nanoparticular vesicle comprises at least a crosslinked hyaluronic acid (HA), wherein the crosslinked hyaluronic acid is crosslinked by a chemical crosslinking agent, and wherein the degree of modification of said crosslinked hyaluronic acid with said chemical crosslinking agent is less than 1.9 mole %. Also disclosed are a method of manufacturing such vesicles, compositions comprising such vesicles and their uses.
    Type: Application
    Filed: June 26, 2019
    Publication date: October 17, 2019
    Inventors: Claire MALLARD, Yves RIVAL
  • Publication number: 20190314649
    Abstract: A micro- or nanoparticular multilamellar vesicle is constituted of concentric membranes comprising at least one non-ionic surfactant of the sucrose ester type comprising at least one chain arising from a linear or branched, saturated or unsaturated, optionally mono- or polyhydroxylated C12 to C22 fatty acid, which vesicle comprises at least a hyaluronic acid (HA), wherein the hyaluronic acid is a crosslinked hyaluronic acid. Also disclosed are a method of manufacture of such vesicle, compositions comprising such vesicle and their uses.
    Type: Application
    Filed: June 26, 2019
    Publication date: October 17, 2019
    Inventors: Claire MALLARD, Yves RIVAL, Lise ANTHONIOZ
  • Publication number: 20190282539
    Abstract: The invention relates to a dermatological or pharmaceutical composition comprising at least one aqueous phase, at least one fatty phase comprising one or more fatty compounds and at least one active phase comprising one or more active compounds chosen from avermectin compounds and one or more solvents and/or propenetrating agents of avermectin compounds, where the composition does not comprise gelling agent. The invention relates also to the composition for use in the treatment of rosacea, of common acne, of seborrheic dermatitis, of perioral dermatitis, of acneiform rashes, of transient acantholytic dermatosis, of acne necrotica miliaris and of atopic dermatitis, and preferably for use in the treatment of rosacea. Finally, the invention relates to a method for preparing the composition.
    Type: Application
    Filed: November 23, 2017
    Publication date: September 19, 2019
    Inventor: Claire MALLARD
  • Publication number: 20190274995
    Abstract: The invention relates to a dermatological or pharmaceutical composition comprising at least one aqueous phase and at least one fatty phase comprising one or more fatty compounds different from solvents and/or propenetrating agents of avermectin compounds and at least one active compound chosen from avermectin compounds, where the composition comprises neither solvents nor propenetrating agents of avermectin compounds. The invention relates also to the composition for use in the treatment of rosacea, of common acne, of seborrheic dermatitis, of perioral dermatitis, of acneiform rashes, of transient acantholytic dermatosis, of acne necrotica miliaris and of atopic dermatitis, and preferably for use in the treatment of rosacea. Finally, the invention relates to a method for preparing the composition.
    Type: Application
    Filed: November 23, 2017
    Publication date: September 12, 2019
    Inventor: Claire MALLARD